Clinical Trial

LASER and Radiofrequency and Genitourinary Syndrome of Menopause

Study acronym: EPMLARF-arm1
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 22, 2025 (before its estimated August 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a randomized controlled trial to evaluate the use of LASER, Micro Ablative radiofrequency and topic strogen to treat symptoms of vulvovaginal atrophy of post menopause.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2019-08-01; most recent amendment 2025-04-21.
Status change: Enrolling by Invitation → Active, Not Recruiting 2025-04-21
Status change: Not Yet Recruiting → Enrolling by Invitation 2023-09-12
Trial Details
NCT Number NCT04045379
Lead Sponsor Federal University of São Paulo
Collaborators: Fundação de Amparo à Pesquisa do Estado de São Paulo
Conditions Postmenopausal Atrophic Vaginitis, Postmenopausal Symptoms, Genitourinary Symptoms
Enrollment 195 participants
Start Date 2019-08-05
Primary Completion 2025-08 (estimated)
Study Completion 2025-08 (estimated)
Updated on ClinicalTrials.gov 2025-04-22